Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 194.99
-1.73 (-0.88%)
Jul 31, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 259.61 billion as of July 31, 2026. Its market cap has decreased by -2.91% in one year.
Market Cap
259.61B
Enterprise Value
303.17B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
194.99
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 259.61B, an increase of 14.50%. That is a compound annual growth rate of 3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 259.61B | 13.53% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 618.10B |
| Ipca Laboratories | 446.21B |
| Ajanta Pharma | 429.16B |
| Gland Pharma | 414.69B |
| Emcure Pharmaceuticals | 362.29B |
| Wockhardt | 309.39B |
| Eris Lifesciences | 190.56B |
| NATCO Pharma | 166.55B |